Vertex’ late-stage Cystic Fibrosis trial meets goals By: MarketWatch June 24, 2014 at 07:58 AM EDT Treatment combined with its Kalydeco drug greatly aided lung function. Read More >> Related Stocks: Vertex Pharmaceuticals